Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiuhua hemorrhoids suppository is a Traditional Chinese Medicine (TCM) formulation developed by the Affiliated Hospital of the Hunan Academy of Traditional Chinese Medicine and manufactured by Hunan Jiuhua Pharmaceutical. It is primarily indicated for the treatment of internal, external, and mixed hemorrhoids, as well as related conditions such as anal fissures and proctitis. The suppository is composed of several herbal ingredients, including *Radix Sanguisorbae* (Diyu), *Radix Angelicae Sinensis* (Danggui), *Radix Scutellariae* (Huangqin), *Coptis chinensis* (Huanglian), *Radix et Rhizoma Rhei* (Dahuang), and *Borneolum Syntheticum* (Bingpian). These components work synergistically to clear heat, detoxify, cool the blood to stop bleeding, and promote the healing of damaged tissues. Clinically, it is applied rectally to reduce symptoms such as anal swelling, pain, and hematochezia through local anti-inflammatory and analgesic actions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiuhua hemorrhoids suppository.